CLOs on the Move


 
At Tegria, we believe that the right technology and tools can help make care more effective for more people. Launched in 2020 with support from Providence, one of the country`s largest health systems, Tegria combines innovative technologies and services to create powerful solutions that simplify healthcare for everyone involved. We built Tegria to make a difference, not only for our customers, but for our communities. We deliver complete solutions to streamline the process of receiving and delivering care, from first visit to follow-up and beyond.
  • Number of Employees: 1K-5K
  • Annual Revenue: $500M-1 Billion
  • www.tegria.com
  • 1801 Lind Avenue South West
    Renton, WA USA 98057
  • Phone: N/A

Executives

Name Title Contact Details
Kevin Livesay
Chief Information Officer Profile

Similar Companies

Allergen Research

Aimmune is a clinical-stage biopharmaceutical company advancing a new therapeutic approach, including the development of proprietary product candidates, for the treatment of peanut and other food allergies. Our mission is to improve the lives of people with food allergies by developing and commercializing proprietary desensitization therapies that safely and reliably protect them from accidental exposure to food allergens. We aim to address food allergies by providing a treatment option that goes beyond the current protocols of avoiding exposure to food allergens and carrying epinephrine for administration in case of accidental exposure. Our CODIT™ system is based on extensive independent scientific research demonstrating that most patients with food allergies can become desensitized to the allergens, or proteins, in a particular food through the oral administration of gradually increasing amounts of the allergens. In oral immunotherapy (OIT), a very small amount of an allergen is administered on a daily basis and then regularly increased until desensitization to a certain amount of the allergen has been achieved. We plan to develop and commercialize standardized, pharmaceutical-grade food allergens for our CODIT™ (characterized oral desensitization immunotherapy) system, our system for OIT. Our lead product candidate, AR101, is a standardized, complex mixture of 13 naturally occurring proteins and pharmaceutical-grade ingredients that, with the CODIT system of gradual, controlled updosing and ongoing maintenance dosing, has obtained meaningful desensitization to peanut allergens in our initial clinical studies.

Harborchase-Sterling Heights

Harborchase-Sterling Heights is a Sterling Heights, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

St Cloud Hospital Recovery PLS

St Cloud Hospital Recovery PLS is a Saint Cloud, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MPI Research

MPI Research, Inc. is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. MPI Research, Inc. is based in Mattawan, MI. You can find more information on MPI Research, Inc. at www.mpiresearch.com

Kern Regional Center

Kern Regional Center is one of 21 private, nonprofit regional centers contracted by the State of California through the Department of Developmental Services (DDS) to coordinate community-based services and support for individuals with developmental disabilities and their families. KRC serves nearly 8,000 clients in Kern, Inyo and Mono Counties. Our counties cover approximately 22,000 square miles with a population of almost 900,000 people